Top 5 Building Product Companies To Buy For 2015


SAN FRANCISCO — A new Qualcomm technology used to create a series of reliable, on-the-fly wireless networks at the South By Southwest Interactive conference earlier this month may soon provide high-end mobile-device users across the U.S. with a new type of digital experience — one that combines their live presence and digital identity.

The quirkily named GIMBAL smartphone technology, which was just transferred from Qualcomm Labs to the chip maker’s retail services unit, may also prove a watershed for cellular consumers willing to trade location privacy for shopping deals and convenience.


If it proliferates, GIMBAL-powered devices could spur more location-based digital content and advertising — outside the need for Internet Wi-Fi service.

The mobile technology proved itself at the SXSW show in Austin by helping a Vancouver, British Columbia-based wireless events start-up automatically establish — and later dismantle — a series of secure, ad-hoc ne tworks for 150 (truly) interactive sessions of the confab.

Top 5 Building Product Companies To Buy For 2015: Sandridge Mississippian Trust II (SDR)

SandRidge Mississippian Trust II is a statutory trust formed to own overriding royalty interests to be conveyed to the trust by SandRidge Energy, Inc. (SandRidge) in 67 producing horizontal wells, including 13 wells, which are awaiting completion (the Producing Wells), in the Mississippian formation in northern Oklahoma and southern Kansas, and overriding royalty interests in 206 horizontal development wells (The Development Wells) to be drilled in the Mississippian formation (the Development Wells) on properties within an Area of Mutual Interest (the AMI). SandRidge is an independent oil and natural gas company engaged in the development and production activities related to the exploitation of its holdings in West Texas and the Mid-Continent area of Oklahoma and Kansas. The AMI, which is limited to the Mississippian formation, consists of approximately 81,200 gross acres (53,000 net acres) held by SandRidge. The Bank of New York Mellon Trust Company, N.A. is trustee (the Trustee), and The Corporation Trust Company is a Delaware Trustee (the Delaware Trustee).


The Mississippian formation is encountered at depths between approximately 4,000 feet and 7,000 feet and lies between the Pennsylvanian-aged Morrow formation and the Devonian-aged Woodford Shale formation. Effective as of January 1, 2012, the royalty interests was conveyed from SandRidge’s interest in the Producing Wells and the Development Wells. The royalty interest in the Producing Wells (the PDP Royalty Interest) entitles the trust to receive 80% of the proceeds from the sale of production of oil and natural gas attributable to SandRidge’s net revenue interest in the Producing Wells. The royalty interest in the Development Wells (the Development Royalty Interest) entitles the trust to receive 70% of the proceeds from the sale of oil and natural gas production attributable to SandRidge’s net revenue interest in the Development Wells.


As of December 31, 2011, the total proved reserves estimated to be attributable to t! he trust were 26.1 million barrels of oil equivalent. This amount includes 10.2 million barrels of oil equivalent attributable to the PDP Royalty Interest and 15.9 million barrels of oil equivalent attributable to the Development Royalty Interest. The proved reserves consist of 46.8% oil and 53.2% natural gas. In addition, as of December 31, 2011, there were 9.8 million barrels of oil equivalent of probable reserves estimated to be attributable to the trust, all of which were attributable to the Development Royalty Interest. The probable reserves consist of 46.9% oil and 53.1% natural gas.


SandRidge will retain 20% of the proceeds from the sale of oil and natural gas attributable to its net revenue interest in the Producing Wells, as well as 30% of the proceeds from the sale of future production attributable to its net revenue interest in the Development Wells. SandRidge initially will own 48.2% of the trust units. SandRidge operates 79% of the Producing Wells. The completed Producing Wells and 121 other Mississippian wells outside of the AMI that have been completed by SandRidge have an average perforated length of approximately 4,200 feet. SandRidge Exploration and Production, LLC (SandRidge E&P), a wholly owned subsidiary of SandRidge, will grant to the trust a lien on its interests in the AMI.


The Underlying Properties are located in Noble, Kay, Alfalfa, Grant and Woods counties in northern Oklahoma and Harper, Comanche, Sumner and Barber counties in southern Kansas in the Mississippian formation, which is an expansive carbonate hydrocarbon system located on the Anadarko Shelf. The Mississippian formation can reach 1,000 feet in gross thickness and the targeted porosity zone is between 50 and 100 feet in thickness. As of December 31, 2011, there were approximately 43 horizontal rigs drilling in the formation, with 19 of those rigs drilling for SandRidge. As of December 31, 2011, SandRidge had approximately 1.5 mill ion net acres leased in the Mississippian formation in north! ern Oklah! oma and Kansas.


Advisors’ Opinion:

  • [By Jim Royal]

    Oscar Wilde once said that experience is the name we give to our mistakes. My investment in Sandridge Mississippian Trust II (NYSE: SDR  ) has been the greatest experience of my Special Situations portfolio. But in investing, as in life, to be successful you must make the next right decision, rather than foolishly holding to a past commitment that has been proven wrong. So I’ve decided to sell my shares in this troubled royalty trust and move on to find a good investment. (I’ve got a good one here.)

  • [By Matt DiLallo]

    The problem here is that SandRidge has been dependent on asset sales and its running out of assets to sell. In addition to the Permian sale, SandRidge has now taken three royalty trusts public. One consisting of Permian Basin assets, SandRidge Permian Trust (NYSE: PER  ) and two consisting of Mississippian assets, SandRidge Mississippian Trust I (NYSE: SDT  ) and SandRidge Mississippian Trust II (NYSE: SDR  ) . While SandRidge still owns a portion of each trust, it likely will continue to sell off its ownership stake in each trust as well as other assets it still owns. At some point SandRidge will need to live within its oil and gas cash flows, otherwise, its not worth owning. 

  • [By Dan Caplinger]

    SandRidge has made a huge bet on the Mississippian Lime shale play, especially after selling off its Permian Basin assets late last year. Unfortunately, that bet hasn’t paid off well for shareholders, as the company saw its spun-off royalty trusts SandRidge Mississippian Trust I (NYSE: SDT  ) and SandRidge Mississippian Trust II (NYSE: SDR  ) fail to meet their projections for distribution amounts during the first quarter. The main problem has been that wells in the Mississippian Lime have produced more natural gas than expected, and even with a slight rebound in gas prices, it still doesn’t produce adequate margins compared to oil and natural-gas liquids.

Top 5 Building Product Companies To Buy For 2015: Karoon Gas Australia Ltd (KRNGF)


Karoon Gas Australia Ltd (Karoon Gas) is an Australia-based exploration company. The Company is principally engaged in the hydrocarbon exploration and evaluation in Australia, Brazil and Peru. The Company operates in three segments: Australia, Brazil and Peru exploration. The Company’s Australia segment is involved in the exploration and evaluation of hydrocarbons in four offshore permit areas: WA-314-P, WA-315-P, WA-398-P and WA-482-P; The Company in its Brazil segment is involved in the exploration and evaluation of hydrocarbons in five offshore blocks including Block S-M-1037, Block S-M-1101, Block S-M-1102, Block S-M-1165 and Block S-M-1166. The Company under its Peru exploration segment is involved in the exploration and evaluation of hydrocarbons in two blocks in Peru, including Block 144 (onshore) and Block Z-38 (offshore). Advisors’ Opinion:

  • [By MARKETWATCH]

    LOS ANGELES (MarketWatch) — Australian stocks gave ground in early Friday trading, with banks broadly lower after overnight losses in the U.S., where investors worried that better-than-expected data would prompt the Federal Reserve to roll back stimulus soon. The S&P/ASX 200 (AU:XJO) lost 0.4% to 5,178.30, as National Australia Bank Ltd. (AU:NAB) (NAUBF) fell 1.8%, Australia & New Zealand Banking Group (AU:ANZ) (ANEWF) lost 0.8%, and Macquarie Group Ltd. (AU:MQG) (MCQEF) retreated 1.3%. Among the resource shares, losses for gold both in New York and in early Asian electronic trade helped send Evolution Mining Ltd. (AU:EVN) (CAHPF) down 1.9% and Kingsgate Consolidated Ltd. (AU:KCN) (KSKGF) off 4.5%, though Newcrest Mining Ltd. (AU:NCM) (NCMGF) held the drop to 0.4%. Oil prices managed a modest gain, however, resulting in a 0.2% rise for Oil Search Ltd. (AU:OSH) (OISHF) and Karoon Gas Australia Ltd. (AU:KAR) (KRNGF) , while Woodside Petroleum Ltd. (AU:WPL)

  • [By MARKETWATCH]

    LOS ANGELES (MarketWatch) — Australian stocks seesawed in early Monday trade, with gains for miners and energy names helping support the market, as the S&P/ASX 200 (AU:XJO) sat 0.1% higher at 5,325.90 after changing direction several times. Official Chinese data showing manufacturing holding its growth rate in October appeared to help some miners, as did gains for some commodity prices. Shares of Rio Tinto Ltd. (AU:RIO) (RIO) rose 0.5%, Fortescue Metals Group Ltd. (AU:FMG) (FSUMF) added 0.7%, Oz Minerals Ltd. (AU:OZL) (OZMLF) advanced 1%, and Whitehaven Coal Ltd. (AU:WHC) improved by 1.9%. Likewise, an advance for gold futures sent Newcrest Mining Ltd. (AU:NCM) (NCMGF) rallying 3.4%, and Kingsgate Consolidated Ltd. (AU:KCN) (KSKGF) up 2.9%. Energy shares also traded higher, with Oil Search Ltd. (AU:OSH) (OISHF) up 1.3%, and Karoon Gas Australia Ltd. (AU:KAR) (KRNGF) adding 1.7%. On the downside, retailers were mostly lower, with David Jones Ltd. (AU:DJS) (DVDJF)

Top 5 Building Product Companies To Buy For 2015: New York Mortgage Trust Inc.(NYMT)


New York Mortgage Trust, Inc., together with its subsidiaries, operates as a real estate investment trust (REIT) in the United States. The company engages in acquiring, investing, financing, and managing mortgage-related assets. It primarily invests in agency residential adjustable-rate, hybrid adjustable-rate, and fixed-rate mortgage-backed securities (RMBS); non-Agency RMBS; prime adjustable-rate residential mortgage loans held in securitization trusts; commercial mortgage-backed securities; commercial mortgage loans; and other commercial real estate-related debt investments. The company has elected to be taxed as a REIT and will not be subject to federal income tax if it distributes at least 90% of its REIT taxable income to its stockholders. New York Mortgage Trust, Inc. was founded in 1989 and is headquartered in New York, New York.


Advisors’ Opinion:

  • [By Lawrence Meyers]

    Next Page

    Preferred Stocks: New York Mortgage Trust (NYMT)

    Dividend Yield: 8.2%

    New York Mortgage Trust (NYMT) is a mortgage real estate investment trust, or mREIT, that acquires, invests in, finances and manages mortgage related securities. These mREITs are very much tied to interest rates, so while rates are low, the stocks will do well. NYMT common stock, in fact, yields more than 14%. Yet that’s why I would choose the New York Mortgage Trust 7.75% Preferred Series B (NYMTP).

  • [By Eric Volkman]

    Investors are being rewarded for putting their trust in New York Mortgage Trust (NASDAQ: NYMT  ) . The REIT has declared a common stock dividend for its current quarter of $0.27 per share, to be paid on July 25 to shareholders of record as of June 28. That amount matches each of the company’s preceding four distributions, the most recent of which was doled out at the end of April. Before that, it paid $0.25 per share.

  • [By Amanda Alix]

    More mREITs stay the course, but two trim payouts
    Despite suffering many tumbles and bruises, several mREITs have announced that their dividends will be unchanged from the previous quarter. Several did so last week, and yesterday saw Hatteras Financial (NYSE: HTS  ) , an agency-only trust, keeping its own $0.70 per share payout the same. Hybrid New York Mortgage Trust (NASDAQ: NYMT  ) also kept its dividend stable, at $0.27 per share, in line with its four most recent distributions.

Top 5 Building Product Companies To Buy For 2015: Nuveen Tax-Advantaged Total Return Strategy Fund (JTA)


Nuveen Tax-Advantaged Total Return Strategy Fund operates as a diversified and closed-end management investment company. The fund primarily invests in dividend-paying common stocks. It also invests in senior loans, U.S corporate bonds, notes and debentures, convertible debt securities, as well as high yield debt securities. Its portfolio primarily includes investments in oil and gas, diversified telecommunication, services, diversified financial services, tobacco, insurance, aerospace and defense, metals and mining, commercial banks, electric utilities, thrifts and mortagage finance, and paper and forest product sectors. Nuveen Tax-Advantaged Total Return Strategy Fund was organized in 2003 and is based in Chicago, Illinois.


Advisors’ Opinion:

  • [By Dividends4Life]

    According to a Gabelli Funds report, managed distribution policies offer several advantages, including:1. Lower difference between the fund’s market price and its NAV per share.2. Provides support during periods when the stock market is in a decline.3. Provides a measurable performance target for the investment adviser.Below are several high-yield funds from CEFA that have a managed distribution policy (yields as of December 16):Aberdeen Australia Eqty (IAF)- Distribution Yield: 10.4%- Income Yield: 346%Bexil Advisers LLC  (DNI)- Distribution Yield: 11.1%- Income Yield: 3.56%BlackRock En Capital&Inc (CII)- Distribution Yield: 8.78%- Income Yield: 2.34%Cornerstone Strat Value (CLM)- Distribution Yield: 18.77%- Income Yield: 1.83%Cornerstone Total Return (CRF)- Distribution Yield: 19.10%- Income Yield: 0.85%Delaware Inv Div & Inc (DDF)- Distribution Yield: 6.70%- Income Yield: 5.26%Gabelli Equity Trust (GAB)- Distribution Yield: 7.58%- Income Yield: 1.54%Gabelli Utility Trust (GUT)- Distribution Yield: 9.45%- Income Yield: 2.84%MFS Special Value Trust (MFV)- Distribution Yield: 9.60%- Income Yield: 5.73%Nuveen Tx-Adv TR Strat (JTA)- Distribution Yield: 6.70%- Income Yield: 3.12%TCW Strategic Income (TSI)- Distribution Yield: 10.54%- Income Yield: 7.88%Zweig Total Return (ZTR)- Distribution Yield: 7.27%- Income Yield: 1.95%As noted in the Gabelli report, a managed distribution policy may create confusion regarding the true current yield since the reported yield includes the return of capital portion. You can see the disparity above between the income yield and the distribution (reported) yield.If you are looking for a sustainable and growing dividend, you may want to consider some blue-chip dividend stocks such as these with a Free Cash Flow Payout less than 50%, 50+ years of consecutive dividend increases and a 2%+ yield:3M Co. (MMM) is a diversified global company provides enhanced product functionality in electronics, health care, industrial, consumer

Top 5 Building Product Companies To Buy For 2015: AcelRx Pharmaceuticals Inc.(ACRX)


AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain in the United States. The company develops ARX-01, a Sufentanil NanoTab PCA system, which completed Phase II clinical trial for acute post-operative pain. The Sufentanil NanoTab PCA system consists of sufentanil, a high therapeutic index opioid; NanoTabs, a non-invasive sublingual dosage form; and a handheld PCA device that enables simple patient-controlled delivery of NanoTabs in the hospital setting and eliminates the risk of programming errors. Its products also include ARX-02, a Sufentanil NanoTab BTP Management System that completed Phase II clinical trial for the treatment of cancer breakthrough pain; and ARX-03, a Sufentanil/Triazolam NanoTab, which completed Phase II clinical trial to provide mild sedation, anxiety reduction, and pain relief for patients undergoing painful procedures in a ph ysician?s office. The company was formerly known as SuRx, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Redwood, California.


Advisors’ Opinion:

  • [By Sean Williams]

    AcelRx Pharmaceuticals (NASDAQ: ACRX  ) received a nice boost from Jefferies this week, after an analyst there initiated coverage on the company with a “buy” rating and a price target of $8, implying about 33% upside from Friday’s close. The covering analyst, Corey Davis, is forecasting that AcelRx’s post-operative pain management drug/system, sufentanil NanoTab PCA — which allows patients to give themselves a pre-set dose of sufentanil under their tongue instead of intravenously — will be approved by the FDA in 2014 and become up to a $400 million drug in the United States. AcelRx’s delivery system does drastically reduce the potential for infections and dosing errors, but I always remain concerned when pain medication systems go before the FDA. In essence, I’d still tread cautiously around this story.

  • [By Sean Williams]

    The good
    Heralding the charge higher was AcelRx Pharmaceuticals (NASDAQ: ACRX  ) which advanced 18% on the week after disclosing on Tuesday that its post-operative pain management system, Sufentanil NanoTab PCA, met its primary endpoint in late-stage trials and reconfirmed all previous late-stage study results. This data is strong enough for AcelRx to seek approval from the Food and Drug Administration with a new drug application filing expected next quarter. I’d be cautious with AcelRx moving forward, as the possibility of an FDA rejection for opioid-based treatments is always a possibility.

  • [By Eric Volkman]

    AcelRx (NASDAQ: ACRX  ) is going to market for a fresh round of funding. The company announced it will float shares of its common stock in an underwritten public flotation. Additionally, the firm expects to grant the issue’s underwriters a 30-day purchase option for up to an additional 15% of the total amount of the shares in the offering.

  • [By Eric Volkman]

    AcelRx (NASDAQ: ACRX  ) has slapped a price tag on its recently announced common stock offering. The company’s shares will be sold to the market in an underwritten public flotation at a cost of $11.65 apiece. The firm has also granted its underwriters a 30-day purchase option for up to an additional 570,000 shares.